1111111111

Board of Directors

President

Laura Feltri, MD

Milan, Italy

(2023-2025)

President-Elect

Charlotte Sumner, MD

Johns Hopkins University School of Medicine, Baltimore, MD, USA

(2023-2025)

Secretary/Treasurer

Michael Polydefkis, MD, MHS

Johns Hopkins Medicine, Baltimore, MD, USA

(2017-2025)

Immediate Past President

Richard Lewis, MD

Cedars-Sinai, Los Angeles, CA, USA

(2023-2025)

Board Members

David Cornblath, MD

Baltimore, MD, USA

(2023 – 2027)

Daniela Maria Menichella. MD, PhD

Northwestern University, Chicago, IL, USA

(2023-2027)

Luis Querol, MD, PhD

Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

(2023-2027)

Stefano C. Previtali, MD, PhD

IRCCS San Raffaele Scientific Institute, Milan, Italy

(2021-2025)

Peter Van den Bergh, MD, PhD, FEAN, FAAN

University Hospital St-Luc, Brussels, Belgium

(2021-2025)

Claudia Sommer, MD

University Hospital Würzburg, Würzburg, Germany

(2021-2025)

Special Interest Group (SIG) Representatives – Non-Voting

Inflammatory Neuropathy Consortium (INC)

Luis Querol, MD, PhD

Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

(2023-2025)

International Diabetes Neuropathy Consortium (IDNC)

Douglas Wright, PhD

University of Kansas Medical Center, Kansas City, KS, USA

(2022-2024)

Charcot-Marie-Tooth & Related Neuropathies Consortium (CMTR)

Mary Reilly, MD

UCL Queen Square Institute of Neurology, London, UK

(2023-2025)

Neuropathic Pain Consortium (NPC)

 

Cheryl L. Stucky, PhD

Medical College of Wisconsin, Milwaukee, WI, USA

(2022-2024)

Toxic Neuropathy Consortium (TNC)

Guido Cavaletti, MD

University of Milano-Bicocco, Monza (I), Milan, Italy

(2020-2026)

Non-Voting Board Members

JPNS Editor-in-Chief

Giuseppe Lauria, MD

Carlo Besta Neurological Institute, Milan, Italy

(2019-2027)

Junior Committee Representative

Kathryn Moss, PhD

Johns Hopkins University, Baltimore, MD, USA

(2021-2024)